Allergic, hypersensitivity reactions are amplified immunologic responses triggered by allergen, or antigen stimulation in previously sensitized individuals. The sensitization occurs from the identical antigen that triggers future allergic reaction, or from a different antigen sharing similar molecular structures.
Four main hypersensitivity reactions are classified by the immune system components involved:
Type I reactions are anaphylactic or immediate-type hypersensitivity reactions. Antigens bind to and cross-link IgE antibodies, causing mast cells to release inflammatory mediators. Examples of Type I reactions include anaphylaxis, allergic rhinitis, and asthma.
Type II reactions involve the activation of the classic complement system by IgG or IgM antibodies, which causes lysis and destruction of cells. Examples include ABO incompatibility, drug-induced hemolytic anemia, and heparin-induced thrombocytopenia.
Type III reactions primarily involve immune complexes of antigens and antibodies bound together. Deposition of immune complexes in tissues activates neutrophils and triggers the complement system. An example of Type III reaction is serum sickness.
Type IV reactions, or delayed hypersensitivity reactions, are characterized by antigen-to-lymphocyte binding. They primarily result in proliferation of cytotoxic T lymphocytes with the purpose of extinguishing antigen-bearing triggering cell. These particular reactions occur within 24 hours, peak from 40-80 hours and resolve by 96 hours. Examples include graft-versus-host reactions, tuberculin immunity as well as contact dermatitis.
Type I immediate hypersensitivity reactions begin when a susceptible individual is exposed to an antigen. During primary exposure, antigen is processed by the antigen-presenting cell (APC). APC then presents antigen’s processed peptide to CD4+ T cells, inducing CD4+ T cell production of IL-4, IL-5, IL-6, IL-10, and granulocyte-macrophage colony-stimulating factor (GM-CSF). These factors stimulate B cells to switch their immunoglobulin production to peptide-specific IgE. Newly produced IgE antibodies are released from B cells and bind to IgE receptors on mast cells and basophils in peripheral tissue and circulation. The IgE antibodies are fixated on the membrane of basophils and mast cells by the Fc receptors. Upon secondary exposure, the allergen binds to IgE, causes cross-linking, and stimulates the basophils and mast cells to degranulate and release their inflammatory vasoactive mediators—prostaglandins, leukotrienes, histamines, and tryptase. The sudden release of these mediators causes arteriolar vasodilatation with increased vascular permeability, bronchiolar smooth muscle constriction, and increased mucus secretions. The degree of immediate hypersensitivity responses varies from mild allergic rhinitis or atopic dermatitis to life-threatening angioedema and anaphylaxis.
Anaphylaxis is a severe, unanticipated, Type I reaction with a variety of respiratory, cardiovascular, gastrointestinal, and cutaneous signs and symptoms (Table 105-1). These manifestations are driven by active mediators, including histamines, released by antigen-IgE stimulated basophils and mast cells, which cause smooth muscle contraction, vascular permeability, and leukocyte and platelet aggregation. Severe symptoms include cardiovascular collapse and pulmonary edema.
Clinical Manifestations of Anaphylaxis
Log In to View More
If you don't have a subscription, please view our individual subscription options below to find out how you can gain access to this content.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
AccessAnesthesiology Full Site: One-Year Subscription
Connect to the full suite of AccessAnesthesiology content and resources including procedural videos, interactive self-assessment, real-life cases, 20+ textbooks, and more
Pay Per View: Timed Access to all of AccessAnesthesiology
24 Hour Subscription $34.95
48 Hour Subscription $54.95
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.